 | Up a level |
Al-Jameel, W, Gou, X, Forootan, SS, Al Fayi, MS, Rudland, PS 
ORCID: 0000-0002-7491-0846, Forootan, FS, Zhang, J, Cornford, PA ORCID: 0000-0002-7146-9258, Hussain, SA and Ke, Y ORCID: 0000-0001-5341-8644
(2020)
Erratum: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 (Oncotarget (2017) 8 (31041-31056)).
Oncotarget, 11 (31).
3025-.
Al-Jameel, W, Gou, X, Jin, X, Zhang, J, Wei, Q, Ai, J, Li, H, Al-Bayati, A, Platt-Higgins, A, Pettitt, A et al (show 2 more authors)
(2019)
Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ.
Genes and Cancer, 10 (3-4).
80 - 96.
Al-Jameel, W, Gou, X, Jin, X, Zhang, J, Wei, Q, Ai, J, Li, H, Al-Bayati, A ORCID: 0000-0001-8223-6284, Platt-Higgins, A, Pettitt, A et al (show 2 more authors)
(2019)
Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ.
Genes and Cancer, 10 (3-4).
pp. 80-96.
AL Fayi, MS, Gou, X, Forootan, S, Al-Jameel, W, Zhang, J, Bao, Z, Rudland, PS ORCID: 0000-0002-7491-0846, Conford, P, Hussain, S and Ke, Y ORCID: 0000-0001-5341-8644
(2016)
Increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Oncotarget, 7 (50).
pp. 82783-82797.
Al-Jameel, W, Gou, X, Forootan, SS, Al Fayi, MS, Rudland, PS ORCID: 0000-0002-7491-0846, Forootan, FS, Zhang, J, Conford, PA, Hussain, SA and Ke, Y ORCID: 0000-0001-5341-8644
(2017)
Inhibitor SBFI26 suppresses the malignant progression of
castration-resistant PC3-M cells by competitively binding to
oncogenic FABP5.
Oncotarget, 8 (19).
pp. 31041-31056.